431 filings
Page 6 of 22
8-K
w8hn39w40 pr4ctt7vdc
4 Mar 21
Submission of Matters to a Vote of Security Holders
9:21am
DEFA14A
lsocuir gczhu9so2bv7
26 Feb 21
Additional proxy soliciting materials
5:20pm
8-K
813xyuviwsds
24 Feb 21
Other Events
8:05am
8-K
u9ug hxf9b
19 Feb 21
Departure of Directors or Certain Officers
5:19pm
DEFA14A
v4euk95
19 Feb 21
Additional proxy soliciting materials
5:18pm
8-K
suhn wke9bamk
16 Feb 21
Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option
4:08pm
8-K
iewnox1gqqgyjgp
12 Feb 21
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
12:00am
424B5
gzoc61t90himq
11 Feb 21
Prospectus supplement for primary offering
5:30pm
424B5
l3vvy d0yuxnmwwzkm4
10 Feb 21
Prospectus supplement for primary offering
4:35pm
DEFA14A
cysxaf081a4hx
3 Feb 21
Additional proxy soliciting materials
5:15pm
8-K
emjx5s6el5cksb
15 Jan 21
Departure of Directors or Certain Officers
5:15pm
424B5
s6wkgx3bynfxovopk4
8 Jan 21
Prospectus supplement for primary offering
4:10pm
8-K
nedselabdkwgho160zju
8 Jan 21
Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering
9:10am
8-K
5y3fbd4
21 Dec 20
Regulation FD Disclosure
8:13am
8-K
bk9m6
18 Dec 20
Departure of Directors or Certain Officers
5:32pm
8-K
4qqdxowh4q2ssz5at
23 Nov 20
Regulation FD Disclosure
8:07am
8-K
ny3r f7zyge
12 Nov 20
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
4:14pm